These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 13516787)

  • 1. [The six-minute test with glucagonfree insulin (Anderson test) and oral therapy of diabetes with synthetic hypoglycemic drugs; notes on the mechanism of action of hypoglycemic drugs].
    BRUNI B; ALBONICO G; NEIROTTI R
    Minerva Med; 1958 Feb; 49(10):376-80. PubMed ID: 13516787
    [No Abstract]   [Full Text] [Related]  

  • 2. [The six-minute test with glucagon-free insulin (Anderson test) and therapy of diabetes with synthetic hypoglycemic drugs; notes on prognostic criteria of the therapeutic results of hypoglycemic drugs].
    BRUNI B; ALBONICO G; NEIROTTI R
    Minerva Med; 1958 Feb; 49(10):381-3. PubMed ID: 13516788
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of oral hypoglycemic drugs in the metabolic control of patients with gestational diabetes].
    Valdés R E; Soto-Chacón E; Lahsen M R; Barrera H C; Candía P P
    Rev Med Chil; 2008 Jul; 136(7):915-20. PubMed ID: 18949170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral antidiabetic drugs in 2003].
    Ducobu J
    Rev Med Brux; 2003 Sep; 24(4):A361-8. PubMed ID: 14606302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J
    Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern therapy in diabetes mellitus, insulin, and the oral hypoglycemic agents.
    KIRTLEY WR; PECK FB
    Minn Med; 1958 Sep; 41(9):607-13. PubMed ID: 13577645
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on hypoglycemic effect of extract of Balaophora polyandra in mice].
    Tian JY; Ji TF; Su YL; Cong WN; Liu ZL; Ye F
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(12):1194-8. PubMed ID: 17802886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Wenying Y;
    Int J Clin Pract; 2009 Mar; 63(3):522-31. PubMed ID: 19187170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ
    Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notes on the use of sulfanyl ureas in therapy of diabetes mellitus, with special reference to their combination with insulin.
    BALDUINI M
    Minerva Med; 1958 Apr; 49(31):1489-91. PubMed ID: 13552311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK
    Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia in diabetic patients undergoing chronic hemodialysis.
    Sun CY; Lee CC; Wu MS
    Ther Apher Dial; 2009 Apr; 13(2):95-102. PubMed ID: 19379147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulins and oral hypoglycemic agents in pregnancy.
    Homko CJ; Reece EA
    J Matern Fetal Neonatal Med; 2006 Nov; 19(11):679-86. PubMed ID: 17127490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Critical study of the new oral hypoglycemic drugs in ambulatory therapy of 200 cases of diabetes in the aged].
    ANDREANI G
    Minerva Med; 1958 Apr; 49(31):1462-3. PubMed ID: 13552286
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical data on the new antidiabetic drugs in therapy of diabetes mellitus; notes on the behavior of vascular complications.
    GAMBIGLIANI-ZOCCOLI A
    Minerva Med; 1958 Apr; 49(31):1453-5. PubMed ID: 13552278
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin: old wine in new bottle--evolving technology and therapy in diabetes.
    Joshi SR
    J Assoc Physicians India; 2005 Nov; 53():963-72. PubMed ID: 16515237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.